Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer

	Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer
	Yang, Mei 1; Fan, Yanhui 2; Wu, Zhi-Yong 3; Feng, Zhendong 2; Zhang, Qiangzu 2; Han, Shunhua 2; Zhang, Zhonghai 4; Li, Xu 4; Xue, Yiqing 2; Li, Xiaoling 1; Hu, Meixia 1; Li, Jieqing 1; Li, Weiping 1; Gao, Hongfei 1; Yang, Ciqiu 1; Zhang, Chunming 2; Zhang, Liulu 1; Zhu, Teng 1; Cheng, Minyi 1; Ji, Fei 1; Xu, Juntao 2; Cui, Hening 2; Tan, Guangming 4; Zhang, Michael Q.5; Liang, Changhong 1; Liu, Zaiyi 1; Song, You-Qiang 6; Niu, Gang 2; Wang, Kun 1
	2021-02-01
发表期刊	CANCER RESEARCH
ISSN	0008-5472
卷号	81 期号:4 页码:1
收录类别	SCI
语种	英语
WOS研究方向	Oncology
WOS类目	Oncology
WOS记录号	WOS:000618737701207
出版者	AMER ASSOC CANCER RESEARCH
引用统计
文献类型	期刊论文
条目标识符	http://119.78.100.204/handle/2XEOYT63/16897
专题	中国科学院计算技术研究所期刊论文_英文
作者单位	1.Guangdong Prov Peoples Hosp, Guangzhou, Guangdong, Peoples R China 2.Phil Rivers Technol, Beijing, Peoples R China 3.Sun Yat Sen Univ, Shantou Affiliated Hosp, Shantou, Peoples R China 4.Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China 5.Tsinghua Univ, Sch Med, Beijing, Peoples R China 6.Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China
推荐引用方式 GB/T 7714	Yang, Mei,Fan, Yanhui,Wu, Zhi-Yong,et al. Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer[J]. CANCER RESEARCH,2021,81(4):1.
APA	Yang, Mei.,Fan, Yanhui.,Wu, Zhi-Yong.,Feng, Zhendong.,Zhang, Qiangzu.,...&Wang, Kun.(2021).Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer.CANCER RESEARCH,81(4),1.
MLA	Yang, Mei,et al."Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer".CANCER RESEARCH 81.4(2021):1.